Pembrolizumab (Anti-PD-1) and AMG386 (Angiopoietin-2 (Ang-2) in Patients With Advanced Solid Tumor
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
The Methodist Hospital Research Institute
Psyence Australia Pty Ltd
Dana-Farber Cancer Institute
Pfizer
Tizona Therapeutics, Inc
Essen Biotech
A2 Biotherapeutics Inc.
University of Nebraska
Adela, Inc
Second Life Therapeutics
Elephas
Novartis
Elephas
University of Pittsburgh
Medtronic - MITG
Massive Bio, Inc.
UNC Lineberger Comprehensive Cancer Center
Washington University School of Medicine
Institut Claudius Regaud
A2 Biotherapeutics Inc.
Institut Bergonié
ModeX Therapeutics, An OPKO Health Company
University of Alabama at Birmingham
Cancer Research UK
Tempus AI
Arbeitsgemeinschaft medikamentoese Tumortherapie
Memorial Sloan Kettering Cancer Center
Elevation Oncology